Delivery Order SPE2DB24D2215-SPE2DB26FGRYB
- Not listed
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count) under a firm fixed-price contract with an ultimate completion date of November 12, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 19, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $31,892.74 delivery order to AmerisourceBergen Drug Corp for TAGRISSO (80 mg tablets, 30-count package) under a firm fixed-price contract type. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, and represents a competitively awarded non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, leveraging its established...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) under a firm fixed price contract type. This competitive award, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) under a firm fixed price contract. The delivery order, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $127,093.14. The delivery order, awarded on August 27, 2025, is scheduled for ultimate completion by September 18, 2025. This is a competitive award with no set-aside designation, and performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $10,662.57, with an ultimate completion date of June 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at approximately $1 billion through...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count) on August 11, 2025, with completion scheduled for September 2, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $85,128.56 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count packages) on September 23, 2025, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB26FGRYBDelivery Order
The Defense Logistics Agency awarded a $10,662.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packaging) with an ultimate completion date of November 13, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle that runs through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems. AmerisourceBergen's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of branded and generic medications, vaccines, syringes, vials, and specialty medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company serves diverse federal customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism. This specific delivery order for TAGRISSO, an oncology medication, reflects AmerisourceBergen's extensive portfolio of pharmaceutical products and its demonstrated capability to meet federal procurement requirements through open competition across a broad spectrum of medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 10/22/25 |